ASB1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.500600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.106800E-01
Normal-vs-Stage2
1.526420E-01
Normal-vs-Stage3
1.095420E-01
Normal-vs-Stage4
9.770600E-01
Stage1-vs-Stage2
1.955630E-01
Stage1-vs-Stage3
4.175800E-02
Stage1-vs-Stage4
7.165200E-01
Stage2-vs-Stage3
1.467160E-01
Stage2-vs-Stage4
1.144390E-01
Stage3-vs-Stage4
8.861700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.795600E-01
Normal-vs-AfricanAmerican
3.029600E-01
Normal-vs-Asian
1.358960E-01
Caucasian-vs-AfricanAmerican
9.137800E-01
Caucasian-vs-Asian
2.889600E-01
AfricanAmerican-vs-Asian
4.706600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.023800E-01
Normal-vs-Female
3.295600E-01
Male-vs-Female
7.322200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.450000E-01
Normal-vs-Age(41-60Yrs)
4.498200E-01
Normal-vs-Age(61-80Yrs)
2.109200E-01
Normal-vs-Age(81-100Yrs)
9.411900E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.870200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.360000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.475580E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.566400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.330370E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.396800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.185600E-02
Normal-vs-Daily Drinker
9.412000E-02
Normal-vs-Weekly Drinker
2.040000E-01
Normal-vs-Occasional Drinker
9.092400E-01
Normal-vs-Social Drinker
8.437600E-01
Non Drinker-vs-Daily Drinker
3.051400E-01
Non Drinker-vs-Weekly Drinker
2.632800E-01
Non Drinker-vs-Occasional Drinker
6.718200E-03
Non Drinker-vs-Social Drinker
2.988200E-02
Daily Drinker-vs-Weekly Drinker
7.792800E-01
Daily Drinker-vs-Occasional Drinker
3.255700E-02
Daily Drinker-vs-Social Drinker
9.402000E-02
Weekly Drinker-vs-Occasional Drinker
9.100300E-02
Weekly Drinker-vs-Social Drinker
1.664200E-01
Occasional Drinker-vs-Social Drinker
8.611800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.696780E-01
Normal-vs-Grade 2
3.380200E-02
Normal-vs-Grade 3
3.788100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.773000E-01
Grade 1-vs-Grade 3
9.090400E-01
Grade 1-vs-Grade 4
1.696780E-01
Grade 2-vs-Grade 3
3.573200E-01
Grade 2-vs-Grade 4
3.380200E-02
Grade 3-vs-Grade 4
3.788100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.205200E-01
Normal-vs-NonDiabetic
2.168400E-01
Diabetic-vs-NonDiabetic
8.725200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.690200E-01
Normal-vs-NoPancreatitis
1.946370E-01
Pancreatitis-vs-NoPancreatitis
1.680050E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.368600E-01
Normal-vs-N1
1.244220E-01
N0-vs-N1
8.074000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.379400E-01
Normal-vs-TP53-NonMutant
4.231800E-01
TP53-Mutant-vs-TP53-NonMutant
6.050800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
